Inactive Instrument

Company Pharmiva AB (publ)

Equities

PHARM

SE0015530670

Pharmaceuticals

Business Summary

Pharmiva AB (publ) is a Sweden-based medical technology company within FemTech that is focused on research and development of medical products. Pharmiva AB (publ) aims to improve vaginal health and reduce the risk of complications by offering treatments without antibiotics. The company's first product Vernivia is antibiotic- and prescription-free treatment for bacterial vaginosis (BV). The treatment is based on Pharmiva AB's (publ) patented drug delivery platform, Venerol, which contains naturally occurring ingredients. The company has received CE marking class IIa for Vernivia, which means that Pharmiva AB (publ) has the right to sell and market the product within the EEA. Pharmiva AB (publ) is also ISO-certified according to ISO 13485 current design, production, marketing and sales.

Number of employees: 5

Managers

Managers TitleAgeSince
Chief Executive Officer 53 22-08-07
Director of Finance/CFO 63 20-01-31
Sales & Marketing 44 22-01-31
Corporate Officer/Principal 41 21-01-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 59 19-12-31
Chairman 49 14-12-31
Director/Board Member 66 19-12-31
Director/Board Member 59 18-12-31
Director/Board Member 52 19-12-31
Director/Board Member 49 14-12-31
Director/Board Member 51 20-12-31

Company contact information

Pharmiva AB

Sankt Lars Väg 45B

222 70, Lund

+46 766 11 96 61

http://www.pharmiva.com
address Pharmiva AB (publ)(PHARM)
  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. Company Pharmiva AB (publ)